Jon Askaa

Director at Inbiomotion

Jon is chief medical officer of Medical Prognosis, Denmark. He was previously director of companion diagnostics at Genentech Inc where he was responsible for the development and implementation of companion diagnostic assays for Genentech’s targeted therapy programs.

Before that he worked at Dako in Denmark and California, where he was responsible for the development and launching of the HercepTest and several other companion diagnostic assays.